Related Experiment Videos

Using a biologically annotated library to analyze the anticancer mechanism of serine palmitoyl transferase (SPT)

Osamu Sano1, Ken-Ichi Kazetani1, Ryutaro Adachi1

  • 1BioMolecular Research Laboratories, Research Takeda Pharmaceutical Company Ltd. Fujisawa Japan.

FEBS Open Bio
|April 12, 2017
PubMed

Insights

Inhibiting serine palmitoyl transferase (SPT) triggers lung cancer cell death through necrosis. SPT inhibitors increase COX-2 expression, offering potential for novel cancer therapies targeting the necrosis pathway.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Mechanistic understanding is vital for developing effective anticancer drugs.
  • Sphingolipid synthesis plays a role in cellular processes, and its regulation is a target for drug discovery.

Purpose of the Study:

  • To elucidate the mechanism of cell death induced by serine palmitoyl transferase (SPT) inhibition in lung cancer cells.
  • To identify compounds that can suppress SPT inhibitor-mediated cell death and understand their mechanism of action.

Main Methods:

  • Screening a biologically annotated library of diverse compounds using an SPT inhibitor.
  • Analyzing hit compounds to determine their effect on SPT inhibitor-mediated cell death and COX-2 expression.

Main Results:

  • SPT inhibition induced cell death in a lung cancer cell line via a necrosis-dependent pathway.
  • Screening identified suppressors of SPT inhibitor-mediated cell death.
  • SPT inhibitors were found to induce COX-2 expression, leading to necrosis-dependent cell death.

Conclusions:

  • SPT inhibitors represent potential novel therapeutic candidates for cancer treatment by regulating the necrosis pathway.
  • Compound combination screening of biologically annotated libraries is an effective strategy for mechanistic elucidation in drug discovery.

Related Concept Videos